During the corresponding time, Enanta Pharmaceuticals Inc saw a revenue deteriorated by -21.6 % year on year, sequentially revenue fell by -16.32 %. While revenue at the Enanta Pharmaceuticals Inc's corporate clients
Enanta Pharmaceuticals Inc's Comment on Sales, Marketing and Customers
The company serves healthcare providers, physicians, and third-party payors in the United States and other regions. These customers are involved in recommending and prescribing product candidates that receive marketing approval. The markets include federal and state healthcare programs such as Medicare and Medicaid, as well as private insurers. The company's agreements with these customers and payors are regulated by federal and state healthcare laws governing marketing, sales, and distribution practices.
In a significant turn of events for the biotechnology industry, Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage firm focused on developing small molecule drugs for addressing virology and immunology conditions, has announced its intention to appeal a ruling issued by the United States District Court of Massachusetts concerning patent infringement. This ruling pertains to a summary judgment motion filed by Pfizer, Inc. in connection with a lawsuit initiated by Enanta, which seeks damages for what it alleges to be infringement of U.S. Patent No. 11,358,953, commonly referred to as the 953 Patent.The 953 Patent is crucial to Enanta s research and development efforts, particularly in the field of v...
Enanta Pharmaceuticals Inc’s Comment on Sales, Marketing and Customers
The company serves healthcare providers, physicians, and third-party payors in the United States and other regions. These customers are involved in recommending and prescribing product candidates that receive marketing approval. The markets include federal and state healthcare programs such as Medicare and Medicaid, as well as private insurers. The company's agreements with these customers and payors are regulated by federal and state healthcare laws governing marketing, sales, and distribution practices.
Sources:
Enanta Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Enanta Pharmaceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Enanta Pharmaceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
349.14 %